⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VANI News
Vivani Medical, Inc. Common Stock (DE)
Vivani Medical conclut un accord avec Novo Nordisk pour évaluer le NPM-139, un implant miniature à base de sémaglutide à action ultra-prolongée destiné au traitement de l’obésité
globenewswire.com
VANI
Form 8-K
sec.gov
VANI
CLRO
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
globenewswire.com
VANI
ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical
businesswire.com
CLRO
VANI
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
globenewswire.com
CLRO
VANI
Form 8-K
sec.gov
VANI
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker
globenewswire.com
VANI
FDMT
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management
globenewswire.com
VANI
Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention
globenewswire.com
VANI
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026
globenewswire.com
VANI